JP2014520877A - ワクチン接種および診断適用におけるポリオーマウイルスjcペプチドおよびタンパク質 - Google Patents
ワクチン接種および診断適用におけるポリオーマウイルスjcペプチドおよびタンパク質 Download PDFInfo
- Publication number
- JP2014520877A JP2014520877A JP2014520691A JP2014520691A JP2014520877A JP 2014520877 A JP2014520877 A JP 2014520877A JP 2014520691 A JP2014520691 A JP 2014520691A JP 2014520691 A JP2014520691 A JP 2014520691A JP 2014520877 A JP2014520877 A JP 2014520877A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- jcv
- pml
- cells
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2046—IL-7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22071—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11006031A EP2548567A1 (en) | 2011-07-22 | 2011-07-22 | Polyoma virus JC peptides and proteins in vaccination and diagnostic applications |
| EP11006031.6 | 2011-07-22 | ||
| PCT/EP2012/064445 WO2013014134A2 (en) | 2011-07-22 | 2012-07-23 | Polyoma virus jc peptides and proteins in vaccination and diagnostic applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014520877A true JP2014520877A (ja) | 2014-08-25 |
| JP2014520877A5 JP2014520877A5 (cg-RX-API-DMAC7.html) | 2015-09-10 |
Family
ID=46548481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520691A Pending JP2014520877A (ja) | 2011-07-22 | 2012-07-23 | ワクチン接種および診断適用におけるポリオーマウイルスjcペプチドおよびタンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9738690B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2548567A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014520877A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20140062702A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103826653A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012288955B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014001516A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2842543A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201490322A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1198517A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2014000776A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013014134A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150065367A1 (en) * | 2011-12-12 | 2015-03-05 | Janssen Diagnostics Bvba | Polyomavirus peptide sequences |
| US10300116B2 (en) | 2013-06-10 | 2019-05-28 | Ansun Biopharma, Inc. | Treatment for BK polyomavirus infection |
| US9931393B2 (en) | 2013-12-20 | 2018-04-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunogenic JC polyomavirus compositions and methods of use |
| EP2926831A1 (en) * | 2014-03-31 | 2015-10-07 | Ruprecht-Karls-Universität Heidelberg | CD8+ T-cell epitopes from polyomavirus capsid protein VP1 for vaccination |
| WO2016073595A1 (en) * | 2014-11-05 | 2016-05-12 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | T cells and dendritic cells for polyomavirus therapy |
| WO2016104046A1 (ja) * | 2014-12-22 | 2016-06-30 | 日東電工株式会社 | 透明導電性フィルム |
| IT201600083859A1 (it) * | 2016-08-09 | 2018-02-09 | Univ Degli Studi Di Ferrara | Immunosaggio per l’identificazione di anticorpi contro il virus Polioma JC (JCPyV) mediante l’uso di peptidi sintetici. |
| CN113278634B (zh) | 2020-11-16 | 2022-06-28 | 艾棣维欣(苏州)生物制药有限公司 | 一种预防和治疗默克尔细胞癌的新型疫苗 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0967397A (ja) * | 1995-06-23 | 1997-03-11 | Eisai Co Ltd | 抗jcウイルス抗体 |
| JP2000500973A (ja) * | 1995-11-22 | 2000-02-02 | ドイチェス プリマーテンツェントルム ゲゼルシャフト ミット ベシュレンクテル ハフツング | Jc−ウイルスのvp−抗原 |
| JP2003061693A (ja) * | 2001-06-28 | 2003-03-04 | Jenapharm Gmbh & Co Kg | ウイルス様粒子、その製造方法およびその使用 |
| JP2005341864A (ja) * | 2004-06-02 | 2005-12-15 | Japan Science & Technology Agency | Jcウイルスの粒子形成阻害剤 |
| WO2008091398A2 (en) * | 2006-08-31 | 2008-07-31 | Baylor Research Institute | Jc virus vaccine |
| WO2010090757A1 (en) * | 2009-02-05 | 2010-08-12 | Biogen Idec Ma Inc. | Methods for the detection of jc polyoma virus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4840792B2 (ja) | 2001-11-22 | 2011-12-21 | 独立行政法人科学技術振興機構 | JCウイルスagnoを対象としたPMLの治療 |
| AU2003238008A1 (en) | 2002-06-12 | 2003-12-31 | Temple University Of The Commonwealth System Of Higher Education | Method of cell growth inhibition with agnoprotein |
| US7468186B2 (en) * | 2005-07-22 | 2008-12-23 | City Of Hope | Polyomavirus cellular epitopes and uses therefor |
| CN100595765C (zh) * | 2008-06-30 | 2010-03-24 | 腾讯科技(深圳)有限公司 | 基于媒体播放器的关键词内容发布方法及系统 |
| WO2010099205A1 (en) | 2009-02-24 | 2010-09-02 | The Trustees Of The University Of Pennsylvania | Methods for treating progressive multifocal leukoencephalopathy (pml) |
| EP2226392A1 (en) * | 2009-03-03 | 2010-09-08 | Assistance Publique - Hôpitaux de Paris | Method for detecting JCV infection |
| WO2011124652A1 (en) * | 2010-04-08 | 2011-10-13 | Fondazione Centro San Raffaele Del Monte Tabor | Immunodominant peptide of polyomavirus jc and uses thereof |
-
2011
- 2011-07-22 EP EP11006031A patent/EP2548567A1/en not_active Withdrawn
-
2012
- 2012-07-23 EP EP12737822.2A patent/EP2734218A2/en not_active Withdrawn
- 2012-07-23 EA EA201490322A patent/EA201490322A1/ru unknown
- 2012-07-23 KR KR1020147004608A patent/KR20140062702A/ko not_active Withdrawn
- 2012-07-23 US US14/234,065 patent/US9738690B2/en not_active Expired - Fee Related
- 2012-07-23 WO PCT/EP2012/064445 patent/WO2013014134A2/en not_active Ceased
- 2012-07-23 JP JP2014520691A patent/JP2014520877A/ja active Pending
- 2012-07-23 MX MX2014000776A patent/MX2014000776A/es unknown
- 2012-07-23 HK HK14112523.5A patent/HK1198517A1/xx unknown
- 2012-07-23 CN CN201280041815.3A patent/CN103826653A/zh active Pending
- 2012-07-23 AU AU2012288955A patent/AU2012288955B2/en not_active Expired - Fee Related
- 2012-07-23 CA CA2842543A patent/CA2842543A1/en not_active Abandoned
- 2012-07-23 BR BR112014001516A patent/BR112014001516A2/pt not_active IP Right Cessation
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0967397A (ja) * | 1995-06-23 | 1997-03-11 | Eisai Co Ltd | 抗jcウイルス抗体 |
| JP2000500973A (ja) * | 1995-11-22 | 2000-02-02 | ドイチェス プリマーテンツェントルム ゲゼルシャフト ミット ベシュレンクテル ハフツング | Jc−ウイルスのvp−抗原 |
| JP2003061693A (ja) * | 2001-06-28 | 2003-03-04 | Jenapharm Gmbh & Co Kg | ウイルス様粒子、その製造方法およびその使用 |
| JP2005341864A (ja) * | 2004-06-02 | 2005-12-15 | Japan Science & Technology Agency | Jcウイルスの粒子形成阻害剤 |
| WO2008091398A2 (en) * | 2006-08-31 | 2008-07-31 | Baylor Research Institute | Jc virus vaccine |
| WO2010090757A1 (en) * | 2009-02-05 | 2010-08-12 | Biogen Idec Ma Inc. | Methods for the detection of jc polyoma virus |
Non-Patent Citations (5)
| Title |
|---|
| CYTHERIS THE IMMUNE ENHANCING COMPANY: "CYTHERIS ANNOUNCES PUBLICATION OF CLINICAL CASE STUDY COMBINING RECOMBINANT HUMAN INTERLEUKIN-7 (CYT", [ONLINE], JPN5014008768, 30 November 2010 (2010-11-30), ISSN: 0003324165 * |
| JOURNAL OF VIROLOGY, vol. 73, no. 5, JPN6017011797, 1999, pages 4465 - 4469, ISSN: 0003532720 * |
| MONIUSZKO MARCIN: "RECOMBINANT INTERLEUKIN-7 INDUCES PROLIFERATION OF NAIVE MACAQUE CD4+ AND CD8+ T CELLS IN VIVO", JOURNAL OF VIROLOGY, vol. V78 N18, JPN5014008767, September 2004 (2004-09-01), pages 9740 - 9749, ISSN: 0003324164 * |
| PATEL AMILA: "TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AND IDIOPATHIC CD4+ LYMPHOCYTOPENIA", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. V65 N12, JPN5014008766, December 2010 (2010-12-01), pages 2489 - 2492, ISSN: 0003324163 * |
| TAN C S: "PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AND OTHER DISORDERS CAUSED BY JC VIRUS: 以下備考", LANCET NEUROLOGY, vol. V9 N4, JPN5014008771, 1 April 2010 (2010-04-01), GB, pages 425 - 437, ISSN: 0003324162 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US9738690B2 (en) | 2017-08-22 |
| MX2014000776A (es) | 2014-11-26 |
| CN103826653A (zh) | 2014-05-28 |
| CA2842543A1 (en) | 2013-01-31 |
| KR20140062702A (ko) | 2014-05-26 |
| AU2012288955B2 (en) | 2017-06-08 |
| WO2013014134A2 (en) | 2013-01-31 |
| WO2013014134A3 (en) | 2013-05-02 |
| BR112014001516A2 (pt) | 2017-02-14 |
| AU2012288955A1 (en) | 2014-02-20 |
| EP2548567A1 (en) | 2013-01-23 |
| HK1198517A1 (en) | 2015-05-15 |
| EP2734218A2 (en) | 2014-05-28 |
| NZ620196A (en) | 2016-10-28 |
| US20140356320A1 (en) | 2014-12-04 |
| EA201490322A1 (ru) | 2014-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease | |
| AU2012288955B2 (en) | Polyoma virus JC peptides and proteins in vaccination and diagnostic applications | |
| Aly et al. | Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome | |
| RU2721574C2 (ru) | Вакцинная композиция против злокачественной опухоли | |
| US7202034B2 (en) | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses | |
| US20230172986A1 (en) | Treatment and prevention of alloreactivity using virus-specific immune cells expressing chimeric antigen receptors | |
| TWI841576B (zh) | 用於治療傳染病之共受體系統 | |
| US20160032245A1 (en) | Compositions and Methods for Modulating an Immune Response | |
| Anwar Jagessar et al. | The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of γ-herpesvirus infected B cells in the marmoset EAE model | |
| JP2015133982A (ja) | 特異抗原に活性化したcd4+、cd25+t細胞 | |
| US20240376429A1 (en) | Virus-specific immune cells expressing chimeric antigen receptors | |
| JP7495137B2 (ja) | 癌抗原特異的細胞傷害性t細胞 | |
| JP5626990B2 (ja) | Th2細胞誘導用組成物およびTh2型疾患の治療組成物、ならびにこれらの利用 | |
| AU4848899A (en) | Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens | |
| EP3915575A1 (en) | Vaccine formulations | |
| NZ620196B2 (en) | Polyoma virus jc peptides and proteins in vaccination and diagnostic applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150723 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150723 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160526 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160825 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20161024 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161116 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170404 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170629 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170901 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20171228 |